Deal Spotlight
July 21, 2026
3D Bio raises €46M in Series A with Expa
€46M
round size
series-a
stage
The Series A funding round closed on June 29, 2026, with Expa as the sole lead investor. This round marks the company's first institutional investment, bringing total capital raised to €460,000.
3D Bio operates as a software company based in the United States. It is categorized under Software & Developer Tools and is currently at the seed stage of development.
Related insights
- Cross-Country AnalysisNetherlands Startups Stall After Seed at 54.7%, Higher Than Spain’s 43.3%
- Cross-Country AnalysisEnergy sector’s 4.8pp seed funding share gain offsets Healthcare’s 1.6pp loss
- Deal SpotlightSyntetica raises €26.2M Series A backed by Bpifrance, EQT Ventures, EIC Fund, Family Offices, lululemon, Mas, Swen Capital Partners
- Deal SpotlightNeko Health raises €613.7M Series C+ backed by Atomico, BDT & MSD Partners, and others
Explore the full dataset
Brouky tracks 36,000+ investors and 100,000+ investments across 84,000+startups. Search by country, stage, and sector.